Evidence map›Paper›PMID 35205358›Full record

ArticleGenes2022

Jonas Neubauer, Leo Hahn, Johannes Birtel, Camiel J F Boon, Peter Charbel Issa, M Dominik Fischer

Open access · goldAbstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. International journal of ophthalmology · 2025
    Article
  3. Article
  4. AAmerican journal of ophthalmology case reports · 2024
    Article
  5. A natural history study of autosomal dominant GUCY2D-associated cone-rod dystrophy.Documenta ophthalmologica. Advances in ophthalmology · 2023
    Article
  6. Diagnostic Challenges inDiagnostics (Basel, Switzerland) · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

Jonas NeubauerCentre for Ophthalmology, University Hospital Tuebingen, University of Tuebingen, 72076 Tuebingen, Germany.
Leo HahnDepartment of Ophthalmology, Amsterdam UMC, Academic Medical Center, 1105 AZ Amsterdam, The Netherlands.
Johannes BirtelOxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
Camiel J F BoonDepartment of Ophthalmology, Amsterdam UMC, Academic Medical Center, 1105 AZ Amsterdam, The Netherlands.
Peter Charbel IssaOxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.ORCID 0000-0002-0351-6673
M Dominik FischerCentre for Ophthalmology, University Hospital Tuebingen, University of Tuebingen, 72076 Tuebingen, Germany.
University of Oxford · GBAmsterdam UMC Location University of Amsterdam · NLLeiden University Medical Center · NLSTZ eyetrial · DEUniversity of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To report the clinical phenotype and associated genotype of a European patient cohort with

Indexed as

Cone-Rod DystrophiesGuanylate CyclaseAdultFemaleHumansMaleProspective StudiesReceptors, Cell SurfaceRetrospective StudiesVision DisordersGuanylate CyclaseReceptors, Cell Surfacecone dystrophycone–rod dystrophydisease progressioneyeguanylate cyclase 2DGUCY2Dinherited retinal diseaseOCTsymmetryvisual acuity

Identifiers

PMID35205358
PMCPMC8872159
OpenAlexW4210981316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.